Private Equity Bets on Analyzing Your Genes
This article is for subscribers only.
Illumina Inc., private equity firm Warburg Pincus and Sutter Hill Ventures are joining up to form a genetic-sequencing startup called Helix, aiming to reach consumers who want to know what their DNA says about their ancestry and health.
The company has raised more than $100 million and will be based in the San Francisco Bay Area, the partners said in a statement Tuesday. Helix will sequence a customer’s genes and then let the client pick and choose from various providers that offer health, fitness and genealogy analysis.